Prw Wealth Management LLC Bristol Myers Squibb CO Transaction History

Prw Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $205,142 - $240,297	-3,467 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $214,641 - $233,745	3,467 New	3,467 $231,000
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $39,310 - $43,468	-881 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $3,699 - $4,411	-82 Reduced 8.52%	881 $42,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $46,955 - $60,890	963 New	963 $50,000

2,449

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Prw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prw Wealth Management LLC with notifications on news.